These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32709711)

  • 1. Podocyte Integrin-
    Madhusudhan T; Ghosh S; Wang H; Dong W; Gupta D; Elwakiel A; Stoyanov S; Al-Dabet MM; Krishnan S; Biemann R; Nazir S; Zimmermann S; Mathew A; Gadi I; Rana R; Zeng-Brouwers J; Moeller MJ; Schaefer L; Esmon CT; Kohli S; Reiser J; Rezaie AR; Ruf W; Isermann B
    J Am Soc Nephrol; 2020 Aug; 31(8):1762-1780. PubMed ID: 32709711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.
    Madhusudhan T; Wang H; Straub BK; Gröne E; Zhou Q; Shahzad K; Müller-Krebs S; Schwenger V; Gerlitz B; Grinnell BW; Griffin JH; Reiser J; Gröne HJ; Esmon CT; Nawroth PP; Isermann B
    Blood; 2012 Jan; 119(3):874-83. PubMed ID: 22117049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
    Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
    Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
    Soh UJ; Trejo J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
    Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
    Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.
    Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS
    J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-
    Huang C; Zhou Y; Huang H; Zheng Y; Kong L; Zhang H; Zhang Y; Wang H; Yang M; Xu X; Chen B
    J Diabetes Res; 2021; 2021():9570405. PubMed ID: 33778085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C.
    Healy LD; Fernández JA; Aiolfi R; Mosnier LO; Griffin JH
    J Thromb Haemost; 2024 Jul; 22(7):2039-2051. PubMed ID: 38670314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.
    Mosnier LO; Sinha RK; Burnier L; Bouwens EA; Griffin JH
    Blood; 2012 Dec; 120(26):5237-46. PubMed ID: 23149848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc.
    Bock F; Shahzad K; Wang H; Stoyanov S; Wolter J; Dong W; Pelicci PG; Kashif M; Ranjan S; Schmidt S; Ritzel R; Schwenger V; Reymann KG; Esmon CT; Madhusudhan T; Nawroth PP; Isermann B
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):648-53. PubMed ID: 23267072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy.
    Bohovyk R; Khedr S; Levchenko V; Stefanenko M; Semenikhina M; Kravtsova O; Isaeva E; Geurts AM; Klemens CA; Palygin O; Staruschenko A
    Diabetes; 2023 Dec; 72(12):1795-1808. PubMed ID: 37722138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.
    Niessen F; Furlan-Freguia C; Fernández JA; Mosnier LO; Castellino FJ; Weiler H; Rosen H; Griffin JH; Ruf W
    Blood; 2009 Mar; 113(12):2859-66. PubMed ID: 19141861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.
    Soto AG; Smith TH; Chen B; Bhattacharya S; Cordova IC; Kenakin T; Vaidehi N; Trejo J
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3600-8. PubMed ID: 26100877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolae are required for protease-selective signaling by protease-activated receptor-1.
    Russo A; Soh UJ; Paing MM; Arora P; Trejo J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6393-7. PubMed ID: 19332793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.
    Bir N; Lafargue M; Howard M; Goolaerts A; Roux J; Carles M; Cohen MJ; Iles KE; Fernández JA; Griffin JH; Pittet JF
    Am J Respir Cell Mol Biol; 2011 Sep; 45(3):632-41. PubMed ID: 21257925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
    Riewald M; Ruf W
    J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3.
    Burnier L; Mosnier LO
    Blood; 2013 Aug; 122(5):807-16. PubMed ID: 23788139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
    Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
    J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway.
    Li Z; Lian Z; Ma J; Zhang L; Lian X; Liu S; Xie J; Feng Z; Lin T; Zhang H; Liang X
    Bioengineered; 2021 Dec; 12(1):1138-1149. PubMed ID: 33818281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.